Heart failure in children. Part I: clinical evaluation, diagnostic testing, and initial medical management

Abstract Current evidence suggests that almost half of allchildren with cardiomyopathy and symptomatic heartfailure will die or require a cardiac transplant within5 years of diagnosis. The recognition, diagnostic assess-ment, and treatment of heart failure in children aretherefore challenging undertakings, to say the least. Itinvolves an assessment ofcardiac appearance and function,adaptation of the child as a whole, and a diagnosticapproach that evaluates many possible root causes. Thisreview is intended to assist the practicing pediatrician andcardiologist by providing a framework for this diagnosticassessment and to give an overview of the treatmentoptions available for children with heart failure. In this firstpart, we will focus on clinical evaluation, diagnostictesting, and initial medical management. In the secondpart of this series, the maintenance treatment and treatmentoptions applicable when medical treatment is insufficientwill be addressed.Keywords Heartfailure.Cardiomyopathy.Treatment.ChildrenIntroductionHeart failure occurs in children as a consequence ofcongenital or acquired disorders, either systemic or involv-ing only the cardiovascular system. Herein, we review anapproach to the diagnosis and assessment of heart failure asa clinical syndrome in children. Acute-phase stabilizationand medical treatment are discussed. Later, in part 2 of thisseries, we will review the maintenance treatment andintervention options for advanced heart failure, such asdevice therapy and heart transplantation. We will deal withheart failure arising both in infancy and in childhood due toeither structural congenital or primarily cardiomyopathicdisease.Heart failure due to congenital structural heart diseasetypically presents early in life [3], resulting from abnormalcardiac chamber morphology, valvular function, or circula-tory connections. Genetically determined diseases of themyocardium (cardiomyopathies, CM) may occasionally beapparent at birth but more frequently manifest later ininfancy, childhood, or indeed during adult life. In CM, thebasis for heart failure is usually reduced systolic function ofthe left ventricle (LV), although associated diastolicdysfunction is increasingly recognized as an importantcontributing factor in the pathophysiology of heart failurein children [38]. The function of the right ventricle (RV),previously overlooked, has also come under scrutiny, as apotential predictor of adverse outcome in patients with heartfailure [13, 38].Disorders affecting the myocardium are diverse and mayarise from genetic abnormalities often involving sarcomericand structural proteins or can be secondary to an acquireddisease (like myocarditis) or toxic exposure (anthracyclinetoxicity). It is important to note that all known diagnoses

[1]  D. Schriger,et al.  Annals of Emergency Medicine Journal Club. Acutely decompensated heart failure in a county emergency department: a double-blind randomized controlled comparison of nesiritide versus placebo treatment. Answers to May 2008 journal club questions. , 2008, Annals of emergency medicine.

[2]  M. Massin,et al.  Epidemiology of Heart Failure in a Tertiary Pediatric Center , 2008, Clinical cardiology.

[3]  W. Poller,et al.  Prevalence of erythrovirus genotypes in the myocardium of patients with dilated cardiomyopathy , 2008, Journal of medical virology.

[4]  J. Towbin,et al.  Worsening renal function in children hospitalized with decompensated heart failure: Evidence for a pediatric cardiorenal syndrome?* , 2008, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[5]  C. Yancy,et al.  Noninvasive ventilation outcomes in 2,430 acute decompensated heart failure patients: an ADHERE Registry Analysis. , 2008, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[6]  M. Santoro,et al.  Congenital heart disease in live-born children: incidence, distribution, and yearly changes in the Campania Region , 2008, Journal of cardiovascular medicine.

[7]  G. Taylor,et al.  Pediatric Myocarditis: Emergency Department Clinical Findings and Diagnostic Evaluation , 2007, Pediatrics.

[8]  D. Pennell,et al.  Myocardial tissue characterization and the role of chronic anemia in sickle cell cardiomyopathy , 2007, Journal of magnetic resonance imaging : JMRI.

[9]  G. Breithardt,et al.  Chronic kidney disease in patients with chronic heart failure--impact on intracardiac conduction, diastolic function and prognosis. , 2007, International journal of cardiology.

[10]  W. Gersony,et al.  Spontaneous regression of left ventricular dilation in children with restrictive ventricular septal defects. , 2007, The Journal of pediatrics.

[11]  D. Atar,et al.  [Treatment of congestive heart failure]. , 2007, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[12]  L. Lehtonen,et al.  The utility of levosimendan in the treatment of heart failure , 2007, Annals of medicine.

[13]  C. Yancy,et al.  Beyond diuretics: management of volume overload in acute heart failure syndromes. , 2006, The American journal of medicine.

[14]  H. Caron,et al.  Clinical heart failure in a cohort of children treated with anthracyclines: a long-term follow-up study. , 2006, European journal of cancer.

[15]  S. Colan,et al.  Incidence, causes, and outcomes of dilated cardiomyopathy in children. , 2006, JAMA.

[16]  S. Colan,et al.  Factors Associated With Establishing a Causal Diagnosis for Children With Cardiomyopathy , 2006, Pediatrics.

[17]  K. Aaronson,et al.  Risk of death associated with nesiritide in patients with acutely decompensated heart failure. , 2006, JAMA.

[18]  L. Shekerdemian,et al.  Early experience with Levosimendan in children with ventricular dysfunction* , 2006, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[19]  B. Byrne,et al.  Cardiac and Clinical Phenotype in Barth Syndrome , 2006, Pediatrics.

[20]  M. Lesch,et al.  Idiopathic dilated cardiomyopathy as a late complication of healed viral (Coxsackie B virus) myocarditis: historical analysis, review of the literature, and a postulated unifying hypothesis. , 2006, Progress in cardiovascular diseases.

[21]  Harlan M Krumholz,et al.  Renal impairment and outcomes in heart failure: systematic review and meta-analysis. , 2006, Journal of the American College of Cardiology.

[22]  D. Winlaw,et al.  Levosimendan for Low Cardiac Output: A Pediatric Experience , 2006, Journal of intensive care medicine.

[23]  Barry J Maron,et al.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interd , 2006, Circulation.

[24]  P. Chetaille,et al.  Outcome of acute fulminant myocarditis in children , 2006, Heart.

[25]  R. Michler,et al.  Perioperative Effects and Safety of Nesiritide Following Cardiac Surgery in Children , 2006, Journal of intensive care medicine.

[26]  H. Schultheiss,et al.  Viral Persistence in the Myocardium Is Associated With Progressive Cardiac Dysfunction , 2005, Circulation.

[27]  C. O'connor,et al.  Overview of current noninodilator therapies for acute heart failure syndromes. , 2005, The American journal of cardiology.

[28]  M. Gheorghiade,et al.  Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes. , 2005, The American journal of cardiology.

[29]  E. Topol Nesiritide - not verified. , 2005, The New England journal of medicine.

[30]  K. Adams,et al.  In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). , 2005, Journal of the American College of Cardiology.

[31]  L. Moreno,et al.  Cardiac findings in adolescents with anorexia nervosa at diagnosis and after weight restoration , 2005, European Journal of Pediatrics.

[32]  D. O'Leary,et al.  Impaired muscle metaboreflex-induced increases in ventricular function in heart failure. , 2004, American journal of physiology. Heart and circulatory physiology.

[33]  M. Fisher,et al.  Nesiritide Does Not Improve Renal Function in Patients With Chronic Heart Failure and Worsening Serum Creatinine , 2004, Circulation.

[34]  M. Burch Immune suppressive treatment in paediatric myocarditis: still awaiting the evidence , 2004, Heart.

[35]  E. Pesonen,et al.  Pharmacokinetics of levosimendan in pediatric patients evaluated for cardiac surgery , 2004, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[36]  J. Towbin,et al.  Echocardiographic predictors of adverse clinical events in children with dilated cardiomyopathy: a prospective clinical study , 2004, Heart.

[37]  J. Tyberg,et al.  Effects of Exogenous and Endogenous Natriuretic Peptides on Forearm Vascular Function in Chronic Heart Failure , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[38]  N. Akkök,et al.  Cardiac abnormalities in children with systemic lupus erythematosus. , 2003, The Turkish journal of pediatrics.

[39]  F. Muntoni Cardiomyopathy in muscular dystrophies , 2003, Current opinion in neurology.

[40]  H. Schultheiss,et al.  Interferon- (cid:1) Treatment Eliminates Cardiotropic Viruses and Improves Left Ventricular Function in Patients With Myocardial Persistence of Viral Genomes and Left Ventricular Dysfunction , 2003 .

[41]  E John Orav,et al.  The incidence of pediatric cardiomyopathy in two regions of the United States. , 2003, The New England journal of medicine.

[42]  Christopher M O'Connor,et al.  Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study. , 2003, Journal of the American College of Cardiology.

[43]  D. Nelson,et al.  Efficacy and Safety of Milrinone in Preventing Low Cardiac Output Syndrome in Infants and Children After Corrective Surgery for Congenital Heart Disease , 2003, Circulation.

[44]  N. Freemantle,et al.  The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure—a meta‐regression analysis , 2002, European journal of heart failure.

[45]  C. Jurkovitz,et al.  Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study. , 2002, Journal of the American Society of Nephrology : JASN.

[46]  J. Hoffman,et al.  The incidence of congenital heart disease. , 2002, Journal of the American College of Cardiology.

[47]  R. Califf,et al.  Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. , 2002, JAMA.

[48]  F. Alla,et al.  Treatment of Congestive Heart Failure: Interfering the Aldosterone-Cardiac Extracellular Matrix Relationship , 2001, Hypertension.

[49]  B. Clark,et al.  Point prevalence of cardiac abnormalities in children with systemic lupus erythematosus. , 2001, The Journal of rheumatology.

[50]  R. Yates,et al.  Dilated cardiomyopathy in dystrophic epidermolysis bullosa , 2000, Archives of disease in childhood.

[51]  X Marchandise,et al.  Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure. , 1998, Journal of the American College of Cardiology.

[52]  G. Wiesner,et al.  Cardiac Disease in Costello Syndrome , 1998, Pediatrics.

[53]  O. Simell,et al.  Epidemiology of idiopathic cardiomyopathies in children and adolescents. A nationwide study in Finland. , 1997, American journal of epidemiology.

[54]  B Maisch,et al.  Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. , 1996, Circulation.

[55]  D. Sillence,et al.  X linked fatal infantile cardiomyopathy maps to Xq28 and is possibly allelic to Barth syndrome. , 1995, Journal of medical genetics.

[56]  E. Hey,et al.  Death in infancy from unrecognised congenital heart disease. , 1994, Archives of disease in childhood.

[57]  R. R. Wolfe,et al.  Second natural history study of congenital heart defects. Results of treatment of patients with ventricular septal defects. , 1993, Circulation.

[58]  H. Schieffer,et al.  Acute effects of intravenous milrinone in heart failure. , 1989, European heart journal.

[59]  S. Lahiri,et al.  Normalization of the blunted ventilatory response to acute hypoxia in congenital cyanotic heart disease. , 1977, The New England journal of medicine.

[60]  O. Lloyd,et al.  A CASE OF ANOMALOUS LEFT CORONARY ARTERY , 1951, British heart journal.

[61]  S. Gottlieb Chapter 44 – Management of Volume Overload in Heart Failure , 2011 .

[62]  M. Froeschl,et al.  Thyrotoxicosis-an uncommon cause of heart failure. , 2005, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[63]  Ling-Fu Meng Nesiritide in Infants and Children with Congestive Heart Failure , 2005 .

[64]  E. Gilbert-Barness Review: Metabolic cardiomyopathy and conduction system defects in children. , 2004, Annals of clinical and laboratory science.

[65]  H. Schultheiss,et al.  Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. , 2003, Circulation.

[66]  J. Towbin,et al.  Sudden death and cardiovascular collapse in children with restrictive cardiomyopathy. , 2000, Circulation.

[67]  W. Remme,et al.  Preload-dependent hemodynamic effects of milrinone in moderate heart failure. , 1992, Cardiology.

[68]  G. Giboney,et al.  Ventricular septal defect , 2018, Operative Cardiac Surgery.

[69]  G R HERRMANN,et al.  Congestive heart failure. , 1962, Geriatrics.

[70]  S. Griffiths,et al.  Ventricular septal defect. I. Congestive heart failure in infancy. , 1960, Pediatrics.